Urination problems affect millions of men worldwide, often developing so gradually that many dismiss early warning signs.

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Frequent nighttime urination, medically known as nocturia, affects many men as they age. While occasional nighttime bathroom ...

Many people believe that urinary tract infections (UTIs) and incontinence are more common in women, but they can also affect ...

The results of this study indicate that combined treatment with an antimuscarinic agent and an α 1-receptor antagonist for 12 weeks is beneficial for men with lower urinary tract symptoms ...

While it is clear that men with lower urinary ... and nighttime frequency. Another subgroup that might benefit from the addition of extended-release tolterodine to tamsulosin treatment comprises ...